Matthew Keller

Stock Analyst at HC Wainwright & Co.

(2.86)
# 1,830
Out of 5,044 analysts
8
Total ratings
75%
Success rate
17.84%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Keller

Acurx Pharmaceuticals
Sep 30, 2025
Reiterates: Buy
Price Target: $31
Current: $6.30
Upside: +392.06%
FibroGen
Sep 24, 2025
Reiterates: Buy
Price Target: $43
Current: $10.83
Upside: +297.23%
InflaRx
Sep 2, 2025
Assumes: Buy
Price Target: $6
Current: $1.51
Upside: +297.35%
Gyre Therapeutics
Aug 26, 2025
Initiates: Buy
Price Target: $18
Current: $7.72
Upside: +133.16%
Phio Pharmaceuticals
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $2.16
Upside: +548.15%
Galectin Therapeutics
Aug 14, 2025
Reiterates: Buy
Price Target: $6
Current: $5.09
Upside: +17.88%